As representatives of hundreds of thousands of scientists across the country, we write to urge you to adhere to stringent scientific and medical standards as the Food and Drug Administration (FDA) prepares to assess the safety and efficacy of vaccine candidates that are currently in phase III clinical trials.

According to a new report from the National Academies of Sciences, Engineering, and Medicine (NASEM), biological collections - living and natural history specimens, biological materials, and data in museums, stock centers, research centers, and universities - are in need of long-term financial sustainability, digitization, recruitment and support of a diverse workforce, and infrastructure upgrades.

The U.S. Fish and Wildlife Service (USFWS) has issued a new proposed rule that would modify the process of designating critical habitats under the Endangered Species Act (ESA). If finalized, the new regulation could potentially shrink critical habitats, which are areas essential for recovery of a species.

As leaders of the nation's scientific societies, we stand ready to work with the National Science Foundation to address and surmount the challenges that COVID-19 poses to the research enterprise. We urge your continued support for the valuable programming we provide and encourage you to foster a culture of innovation in order to meet the short- and long-term needs of the scientific community

At this time of great challenges for our nation, we write to thank you for your leadership in confronting inequities in the U.S. scientific enterprise that have prevented full participation of racial and ethnic groups underrepresented in STEM.

The Union of Concerned Scientists (UCS) has released a new report, Strengthening Scientific Integrity at Federal Agencies: Recommendations for 2021 and Beyond, which outlines a road map for the next Administration to enhance scientific integrity across federal agencies.

On behalf of the scientific, medical, and patient communities dedicated to advancing human health, we write to express ongoing concerns about the NIH Human Fetal Tissue Ethics Advisory Board and its final report that would block funding for all but one research proposal seeking to use human fetal tissue.

After COVID relief negotiations between White House representatives and Democratic congressional leaders reached an impasse, President Trump signed a series of Executive Orders on August 8, 2020, the White House argued would restore lapsed benefits and address some of the pandemic’s economic impacts.

On July 27, 2020, Republican lawmakers in the Senate unveiled a $1 trillion stimulus package to address the impacts of the ongoing coronavirus pandemic.

On behalf of the scientific, medical, and patient communities dedicated to advancing human health, we write to express our collective, strong support for the continued use of human fetal tissue in life-saving biomedical research.